Title: Targeting Filarial Abl-like Kinases: Orally Available, Food and Drug Administration-Approved Tyrosine Kinase Inhibitors Are Microfilaricidal and Macrofilaricidal.
Authors: O'Connell EM, Bennuru S, Steel C, Dolan MA, Nutman TB
Journal: J Infect Dis
Published: 2015-09-01
Volume: 212
Pages: 684-93